⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—Nippon India Banking & Financial Services Fund - Growth - Direct PlanDirect · Growth
₹653.74 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFNippon India Banking & Financial Services Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Sectoral Fund - Banks & Financial ServicesEquity - Sectoral Fund - Pharma & Health Care
NAV₹653.74 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★
BenchmarkNifty Financial Services - TRIBSE Health Care - TRI
Fund ManagerVinay SharmaNikhil Mathur
Inception01 Jan 201304 Oct 2023
Returns
1Y-7.99%22.64%
3Y10.35%30.41%
5Y11.00%—
Since Inception12.97%29.15%
Risk
14.3214.07
0.920.59
0.311.59
1.8321.67
0.573.48
-15.11%-9.23%
Costs
Expense Ratio1.07%1.03%
Exit Load1% on or before 1M, Nil after 1M1% on or before 30D, Nil after 30D
Min SIP₹100₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
Nippon India …100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between Nippon India Banking & Financial Services Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →